{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:43:54Z","timestamp":1780555434775,"version":"3.54.1"},"reference-count":76,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2020,4,15]]},"DOI":"10.1080\/10428194.2019.1709832","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T05:39:27Z","timestamp":1578548367000},"page":"1063-1074","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Checkpoint inhibition therapy as possible frontline therapy for Hodgkin lymphoma"],"prefix":"10.1080","volume":"61","author":[{"given":"Arushi","family":"Khurana","sequence":"first","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Armand","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Ansell","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,1,8]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21551"},{"key":"e_1_3_2_3_1","unstructured":"Hodgkin L. Cancer stat facts; [cited 2019 Jul 12]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/hodg.html"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-115493"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(96)80018-7"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25071"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30103-1"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30784-8"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510093"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12222"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199211193272102"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.1.27"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505949"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.323"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2019.02.008"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.0793"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411087"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30167-X"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-02-699850"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.3467"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708984"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2435"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.4.1495"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000331"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06964.x"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.8401"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-282780"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.4482"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2009.03.025"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09754"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2542"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1942"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.3994"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00174"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-770719"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1160186"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0201"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1295202"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-796342"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/359748"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022842"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20102416"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-843714"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.1316"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-117045"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.183.183"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-10-811224"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00315"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30192-3"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0545-2"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0004"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.1107.1107"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.585.585"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.1106.1106"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-115390"},{"key":"e_1_3_2_56_1","doi-asserted-by":"crossref","unstructured":"Br\u00f6ckelmann P. Nivolumab and AVD for early-stage unfavorable Hodgkin lymphoma (NIVAHL). Blood. 2019;134(Supplement_1):236.","DOI":"10.1182\/blood-2019-122406"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.104_2629"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-795476"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-113836"},{"key":"e_1_3_2_60_1","doi-asserted-by":"crossref","unstructured":"Br\u00f6ckelmann PJ McMullen S Wilson JB et al. Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany France and the United Kingdom. Br J Haematol. 2019;184:202\u2013214.","DOI":"10.1111\/bjh.15566"},{"key":"e_1_3_2_61_1","doi-asserted-by":"crossref","unstructured":"Kreissl S Goergen H M\u00fcller H et al. Survivors' perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study Group. Leuk Lymphoma. 2018;60:1389\u20131398.","DOI":"10.1080\/10428194.2018.1540781"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-3141"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv209"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0733"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2016.07.013"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40269"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801005"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606774"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-718528"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1624"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2403"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature13954"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1515939"},{"key":"e_1_3_2_74_1","first-page":"3205","article-title":"Late pulmonary toxicity of bleomycin","volume":"16","author":"Willenbacher W","year":"1998","unstructured":"Willenbacher W, Mumm A, Bartsch HH. Late pulmonary toxicity of bleomycin. J Clin Oncol. 1998;16:3205.","journal-title":"J Clin Oncol"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.7243"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.0139"},{"key":"e_1_3_2_77_1","doi-asserted-by":"crossref","unstructured":"O'Dwyer KM Friedberg JW. Chemoimmunotherapy in advanced-stage Hodgkin lymphoma: can we define a unified regimen for all ages? Hematologist. 2019;16(5).","DOI":"10.1182\/hem.V16.5.9848"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2019.1709832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T17:19:24Z","timestamp":1732295964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2019.1709832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,8]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,4,15]]}},"alternative-id":["10.1080\/10428194.2019.1709832"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2019.1709832","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-10-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}